Salfacorp Ownership

SALFACORP  CLP 564.50  0.90  0.16%   
Salfacorp shows a total of 452.5 Million outstanding shares. Salfacorp maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Salfacorp in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Salfacorp, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Salfacorp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Salfacorp Stock Ownership Analysis

About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.27. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Salfacorp recorded earning per share (EPS) of 73.29. The entity last dividend was issued on the 2nd of May 2022. The firm had 174:173 split on the 4th of January 2023. SalfaCorp S.A. engages in engineering and construction, and real estate activities in Chile, Peru, Colombia, Panama, the Caribbean, China, and internationally. SalfaCorp S.A. was founded in 1929 and is based in Santiago, Chile. SALFACORP operates under Engineering Construction classification in Exotistan and is traded on Commodity Exchange. It employs 19005 people. To find out more about Salfacorp contact the company at 56 2 2902 0000 or learn more at https://www.salfacorp.com.

Salfacorp Outstanding Bonds

Salfacorp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Salfacorp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Salfacorp bonds can be classified according to their maturity, which is the date when Salfacorp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pair Trading with Salfacorp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Salfacorp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salfacorp will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Salfacorp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Salfacorp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Salfacorp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Salfacorp to buy it.
The correlation of Salfacorp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Salfacorp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Salfacorp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Salfacorp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Salfacorp Stock

Salfacorp financial ratios help investors to determine whether Salfacorp Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Salfacorp with respect to the benefits of owning Salfacorp security.